ArticleFrontiers in neurology2025
Oculomotor indicators of cognitive performance are modulated by neurodegeneration.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Eye movement characteristics and their correlation with cognitive function in cerebral small vessel disease.Frontiers in neurology · 2026Article
- Multimodal data-driven eye-movement subtypes and their cerebral glucose metabolic patterns in Parkinson's disease.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, the extent to which eye movements can be used to estimate cognitive ability in neurologically intact individuals was evaluated in the absence of clear underlying neurodegenerative processes. In contrast to previous studies of Parkinson's Disease (PD) and multiple sclerosis that demonstrated a strong link between oculomotor parameters and clinical measures of cognition, this relationship is unaffected by disease in healthy participants, enabling a more direct assessment of the connection between eye movements and cognition. Accordingly, a modest portion (≤28%) of the observed variance in cognitive test scores could be explained by oculomotor parameters in 204 participants aged 18-79 with no differences between males and females observed. The relationship between oculomotor parameters and cognitive measures was further compared between neurologically intact individuals and a separate sample of 65 individuals with PD. Oculomotor parameters showed stronger correlations with cognitive measures in PD patients, likely contributing to the greater explanatory power of oculomotor-based models in this population. Finally, given that many oculomotor parameters are affected by age, the ability to estimate an individual's age without confounding neurodegeneration was assessed. As 33% of the variance in participants' age could be explained by oculomotor parameters, age may be estimated from oculomotor parameters, providing insight into the aging brain. Collectively, these findings highlight the connection between oculomotor function and clinical measures of cognition in the absence of neurodegeneration and indicate that these relationships are likely mediated by the functional integrity of brain networks involved in both motor control and cognitive processing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.